Welcome to the website of the UK Chemotherapy Partnership – aiming to improve the quality and safety of chemotherapy delivery by sharing information, expertise and opinion. We open the door on the latest developments in chemotherapy service provision and give you access to NHS experts and their documentation to help you develop and improve your own service.

Chemotherapy service

Chemotherapy delivery can be complex and challenging. These are some of the practice innovations and developments within the UK aiming to improve the patient experience.

18
March 2016
Events & meetings

UKCP Systemic-Anti Cancer Therapy Masterclass
Programme to follow.  

CPD

Coming soon. We are very excited to announce this new online educational resource. It will initially include 6 modules on cancer and chemotherapy.

Our videos

Healthcare professionals sharing experiences of service developments, including patient information videos for patients embarking on the treatment pathway.

What's new

Achieving World-Class Outcomes-A Strategy for England 2015-2020

Five year plan to radically improve cancer outcomes.

MORE
2015 ASCO Annual Meeting-Highlights

Highlights from the 2015 ASCO Annual Meeting-Illumination & Innovation; Transforming Data into Learning

MORE
Recovery Package-Cancer Nursing Partnership

The CNP is working to roll out the Recovery Package

MORE
Understanding Cancer E-Learning

Understanding Cancer was launched in April 2012.

MORE

Latest news

Genetic switch for cancer cells' immortality revealed

Scientists have revealed how a genetic switch involved in the packaging of DNA may be key to a cancer cell’s ability to keep growing. The Francis Crick Institute researchers, part-funded by Cancer Research UK, found that production of a protein called...

MORE
Men with high genetic risk of bowel cancer could lower their risk with healthy lifestyles

MEN with a high genetic risk of developing bowel cancer over the next 25 years could have a lower risk of developing the disease if they also have a healthy lifestyle, according to a Cancer Research UK-funded study published in the journal Genetics in...

MORE
Custom-tailored strategy against glioblastomas

Glioblastomas are among the most common and malignant of brain tumours, and the patients affected usually survive for only a few months.  In addition, every tumour is quite different, which makes treatment very difficult. Researchers at the...

MORE
ADAM inhibition a new hope against glioblastoma

Researchers from the University of Southampton have discovered a potential way of stopping one of the most aggressive types of brain tumour from spreading, which could lead the way to better patient survival. Glioblastoma is one of the most common types...

MORE
Expectations may not match reality among cancer patients in some early phase clinical trials

In a study of cancer patients considering whether they should participate in phase I clinical trials, a high percentage were willing to participate after discussions with clinical staff, but nearly half thought that their tumours would shrink, which is...

MORE